2 results
Approved WMOPending
Determine feasibility and reliability of CDFM in relation to the current strategy of intermittent Doppler US examinations for detection of hepatic artery thrombosis.
Approved WMOWill not start
The primary objectives of this study are to establish the efficacy and safety of APL-2 compared to eculizumab in patients with PNH who continue to have Hb levels <10.5 g/dL despite treatment with eculizumab.